KarXT trials for Schizophrenia

All KarXT trials · All Schizophrenia trials

Phase breakdown

Recruiting trials studying KarXT for Schizophrenia

• A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
  NCT06585787 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · 293 locations
• A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
  NCT06947941 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · 44 locations
• A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
  NCT07288567 · Phase: Phase 3 · Ages: 13 Years to 17 Years · Sex: All (male and female) · 38 locations
• A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia
  NCT06882785 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 56 locations
• A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
  NCT07424404 · Phase: Phase 3 · Ages: 5 Years to 17 Years · Sex: All (male and female) · 91 locations
• A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
  NCT07061288 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 8 locations

Common questions

How many trials study KarXT for Schizophrenia?

6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.